Merck KGaA forecast a sluggish year ahead, with the possibility of falling profits, as generic competition for its multiple ...
Oral anti-obesity formulations will be the next growth lever in Danish drugmaker Novo Nordisk's India strategy, following the 2025 launches of its blockbuster diabetes and obesity brands Ozempic and ...
Bengaluru-based biopharmaceutical major Biocon reported a consolidated net profit of Rs 143.8 crore for the third quarter of 2025–26 (Q3FY26), a rise from a low base of Rs 25.1 crore in the same ...
The Paho Java Client is an MQTT client library written in Java for developing applications that run on the JVM or other Java compatible platforms such as Android The Paho Java Client provides two APIs ...
Muriel, from the Auxiliary of Social Life, works at the home of Mr. T, who has multiple sclerosis, in Pas de Calais, France, on June 11, 2023. (Astier / BSIP via AFP) (CN) — For people living with ...
Last year, the U.S. Senate Special Committee on Aging launched a bipartisan effort to expose the public health and national security risks America’s overreliance on foreign-made generic drugs poses to ...
President Trump on Thursday unveiled his lower-cost drug platform TrumpRx, touting it as “one of the most transformative health care initiatives of all time.” “This launch represents the largest ...
John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. Emory is the data editor at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results